C
Carlos del Rio
Researcher at Emory University
Publications - 548
Citations - 23123
Carlos del Rio is an academic researcher from Emory University. The author has contributed to research in topics: Acquired immunodeficiency syndrome (AIDS) & Population. The author has an hindex of 62, co-authored 513 publications receiving 18830 citations. Previous affiliations of Carlos del Rio include Grady Memorial Hospital.
Papers
More filters
Journal ArticleDOI
The Spectrum of Engagement in HIV Care and its Relevance to Test-and-Treat Strategies for Prevention of HIV Infection
Edward M. Gardner,Margaret P. McLees,John F. Steiner,John F. Steiner,Carlos del Rio,William J. Burman +5 more
TL;DR: The spectrum of engagement in care for HIV-infected individuals in the United States is reviewed and this information is applied to help understand the magnitude of the challenges that pooragement in care will pose to test-and-treat strategies for HIV prevention.
Journal ArticleDOI
Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial.
Susan Buchbinder,Devan V. Mehrotra,Ann Duerr,Daniel W. Fitzgerald,Robin Mogg,David Li,Peter B. Gilbert,Javier R. Lama,Michael Marmor,Carlos del Rio,M. Juliana McElrath,Danilo R. Casimiro,Keith Gottesdiener,Chodakewitz Jeffrey A,Lawrence Corey,Michael N. Robertson +15 more
TL;DR: This cell-mediated immunity vaccine did not prevent HIV-1 infection or reduce early viral level and Mechanisms for insufficient efficacy of the vaccine and the increased HIV- 1 infection rates in subgroups of vaccine recipients are being explored.
Journal ArticleDOI
Mild or Moderate Covid-19.
TL;DR: Covid-19 (the illness caused by SARS-CoV-2) has a range of clinical manifestations, including cough, fever, malaise, myalgias, gastrointestinal symptom...
Journal ArticleDOI
Broadly cross-reactive antibodies dominate the human B cell response against 2009 pandemic H1N1 influenza virus infection
Jens Wrammert,Dimitrios G. Koutsonanos,Gui-Mei Li,Srilatha Edupuganti,Jianhua Sui,Michael Morrissey,Megan McCausland,Ioanna Skountzou,Mady Hornig,W. Ian Lipkin,Aneesh K. Mehta,Behzad Razavi,Carlos del Rio,Nai-Ying Zheng,Jane-Hwei Lee,Min Huang,Zahida Ali,Kaval Kaur,Sarah F. Andrews,Rama Rao Amara,Youliang Wang,Suman R. Das,Christopher D. O'Donnell,J W Yewdell,Kanta Subbarao,Wayne A. Marasco,Mark J. Mulligan,Richard W. Compans,Rafi Ahmed,Patrick C. Wilson +29 more
TL;DR: Although scarce after annual influenza vaccination, B cells producing antibodies capable of neutralizing multiple influenza strains are abundant in humans infected with pandemic 2009 H1N1 influenza.
Journal ArticleDOI
Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults: 2016 Recommendations of the International Antiviral Society–USA Panel
Huldrych F. Günthard,Michael S. Saag,Constance A. Benson,Carlos del Rio,Joseph J. Eron,Joel E. Gallant,Jennifer F Hoy,Michael J. Mugavero,Paul E. Sax,Melanie A. Thompson,Rajesh T. Gandhi,Raphael J. Landovitz,Davey M. Smith,Donna M. Jacobsen,Paul A. Volberding +14 more
TL;DR: In this article, the authors provide updated recommendations for the use of antiretroviral therapy in adults (aged ≥18 years) with established HIV infection, including when to start treatment, initial regimens, and changing regimens along with recommendations for using ARVs for preventing HIV among those at risk, including preexposure and postexposure prophylaxis.